Antiproliferative agents work through various mechanisms. Propranolol reduces the proliferation of endothelial cells in hemangiomas by blocking beta-adrenergic receptors. Sirolimus and Everolimus inhibit the mTOR pathway, which is crucial for cell growth and proliferation. By targeting these pathways, these agents can effectively reduce abnormal cell growth in neonatal disorders.